Patents by Inventor Michael L. Cher

Michael L. Cher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic alterations associated with prostate cancer
    Patent number: 7407759
    Abstract: The present invention provides new probes for the detection of prostate cancer cells. The probes bind selectively with target polynucleotide sequences selected from the group consisting of 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: August 5, 2008
    Assignee: The Regents of the University of California
    Inventors: Ronald H. Jensen, Michael L. Cher
  • Genetic alterations associated with prostate cancer
    Publication number: 20030040005
    Abstract: The present invention provides new probes for the detection of prostate cancer cells. The probes bind selectively with target polynucleotide sequences selected from the group consisting of 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q.
    Type: Application
    Filed: September 12, 2002
    Publication date: February 27, 2003
    Applicant: The Regents of the University of California
    Inventors: Ronald H. Jensen, Michael L. Cher
  • Genetic alterations associated with prostate cancer
    Patent number: 6451529
    Abstract: The present invention provides new probes for the detection of prostate cancer cells. The probes bind selectively with target polynucleotide sequences selected from the group consisting of 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q.
    Type: Grant
    Filed: April 19, 1999
    Date of Patent: September 17, 2002
    Assignee: The Regents of the University of California
    Inventors: Ronald H. Jensen, Michael L. Cher
  • Genetic alterations associated with prostate cancer
    Patent number: 5925519
    Abstract: The present invention provides new probes for the detection of prostate cancer cells. The probes bind selectively with target polynucleotide sequences selected from the group consisting of 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: July 20, 1999
    Assignee: The Regents of the University of California
    Inventors: Ronald H. Jensen, Michael L. Cher